878
F. Szemes Jr. et al.
PAPER
tion, which was then stirred for 15 min and filtered through a Celite
pad. The solvents were carefully removed under vacuum to give
white crystals which were purified by flash chromatography (cyclo-
hexane–EtOAc, 1:1) to give acetoxy lactam 2a1 in 90% yield; mp
83–84 °C; [a]D25 +2.8 (c 0.5, acetone).
13C NMR: d = 20.5, 20.7, 26.8, 43.4, 73.9, 75.9, 83.5, 118.5, 131.1,
167.4, 169.5, 169.7.
2-Benzyl-3-oxo-2,3-dihydro-1H-isoindol-1-yl Acetate (2i)
White solid; mp 73–75 °C.
IR (CHCl3): 1776, 1740, 1709 cm–1.
1H NMR: d = 1.88 (s, 3 H), 4.56 (d, J = 14.8 Hz, 1 H), 4.84 (d, J =
14.8 Hz, 1 H), 6.86 (s, 1 H), 7.13–7.29 (m, 5 H), 7.40–7.54 (m, 3 H),
7.77–7.97 (m, 1 H).
13C NMR: d = 21.0, 44.5, 81.1, 124.0, 127.9, 128.5, 128.9, 130.5,
132.0, 132.8, 136.9, 141.2, 168.1, 171.2.
(2S,3S)-1-Allyl-5-oxopyrrolidine-2,3-diyl Diacetate (2c)
Colorless oil; [a]D25 –32.9 (c 0.9, EtOH).
IR (CHCl3): 1733, 1673, 1644 cm–1.
1H NMR: d = 2.09 (s, 3 H), 2.11 (s, 3 H), 2.59 (dd, J = 9.4, 16.4 Hz,
1 H), 2.73 (dd, J = 7.8, 16.4 Hz, 1 H), 3.66 (dd, J = 7.0, 15.6 Hz, 1
H), 4.12 (dd, J = 5.4, 15.6 Hz, 1 H), 5.07–5.20 (m, 2 H), 5.30 (ddd,
J = 4.7, 7.8, 9.4 Hz, 1 H), 5.60–5.82 (m, 1 H), 6.27 (d, J = 4.7 Hz,
1 H).
2-Vinyl-3-oxo-2,3-dihydro-1H-isoindol-1-yl Acetate (2j)
White solid; mp 70–72 °C.
IR (CHCl3): 1723, 1643 cm–1.
1H NMR: d = 2.11 (s, 3 H), 4.55 (d, J = 16.4 Hz, 1 H), 4.59 (d, J =
9.4 Hz, 1 H), 7.04 (dd, J = 9.4, 16.4 Hz, 1 H), 7.45–7.60 (m, 3 H),
7.80 (d, J = 6.2 Hz, 1 H).
13C NMR: d = 21.1, 79.5, 95.8, 124.3, 124.4, 127.0, 130.9, 131.2,
133.7, 141.1, 165.8, 171.1.
13C NMR: d = 20.8, 21.0, 34.2, 43.8, 66.3, 81.8, 118.9, 131.9, 170.2,
170.4, 171.6.
(2S,3S)-1-Benzyl-3-{[tert-butyl(dimethyl)silyl]oxy}-5-oxopyrro-
lidin-2-yl Acetate (2d)
Colorless oil; [a]D25 +12 (c 0.098, EtOH).
IR (CHCl3): 1745, 1712, 1246, 730 cm–1.
1H NMR: d = 0.02 (s, 3 H), 0.06 (s, 3 H), 0.85 (s, 9 H), 1.95 (s, 3 H),
2.49 (dd, J = 8.6, 15.7 Hz, 1 H), 2.59 (dd, J = 7.8, 15.7 Hz, 1 H),
4.21 (d, J = 14.9 Hz, 1 H), 4.37 (ddd, J = 4.7, 7.8, 8.6 Hz, 1 H), 4.70
(d, J = 14.9 Hz, 1 H), 6.11 (d, J = 4.7 Hz, 1 H), 7.20–7.40 (m, 5 H).
13C NMR: d = –5.0, –4.9, 18.0, 20.9, 25.7, 37.6, 44.8, 66.4, 83.3,
127.9, 128.6, 128.9, 136.3, 170.5, 173.0.
2-Allyl-3-oxo-2,3-dihydro-1H-isoindol-1-yl Acetate (2k)
White solid; mp 62–63 °C.
IR (CHCl3): 1740, 1712, 1645 cm–1.
1H NMR: d = 2.11 (s, 3 H), 3.91 (ddt, J = 1.5, 6.2, 15.6 Hz, 1 H),
4.35 (ddt, J = 1.5, 6.2, 15.6 Hz, 1 H), 5.15–5.24 (m, 2 H), 5.72–5.91
(m, 1 H), 7.00 (s, 1 H), 7.40–7.76 (m, 3 H), 7.78–7.82 (m, 1 H).
13C NMR: d = 21.2, 43.2, 81.2, 118.1, 123.9, 124.1, 130.5, 132.1,
132.7, 132.8, 141.2, 167.8, 171.2.
(2S,3S)-3-{[tert-Butyl(dimethyl)silyl]oxy}-1-(4-methylbenzyl)-
5-oxopyrrolidin-2-yl Acetate (2e)
White solid; mp 51 °C; cis/trans, 92:8.
IR (CHCl3): 1740, 1709, 1248 cm–1.
2-Propenyl-3-oxo-2,3-dihydro-1H-isoindol-1-yl Acetate (2l)
White solid; mp 57–59 °C.
IR (CHCl3): 1739, 1644 cm–1.
1H NMR: d = 1.78 (dd, J = 1.5, 7.0 Hz, 3 H), 2.16 (s, 3 H), 5.20 (qd,
J = 7.0, 14.8 Hz, 1 H), 6.87 (qd, J = 1.5, 14.8 Hz, 1 H), 7.50–7.64
(m, 3 H), 7.78–7.82 (m, 1 H), 7.81–7.86 (m, 1 H).
13C NMR: d = 15.9, 21.2, 80.1, 108.6, 122.0, 124.2, 124.3, 130.8,
131.5, 133.3, 141.1, 165.5, 171.2.
1H NMR: d = 0.00 (s, 3 H, cis, 92%), 0.02 (s, 3 H, cis), 0.12 (s, 3 H,
trans, 8%), 0.15 (s, 3 H, trans), 0.81 (s, 9 H, cis), 0.88 (s, 9 H, trans),
1.95 (s, 3 H, cis), 2.02 (s, 3 H, trans), 2.47 (dd, J = 8.6, 15.7 Hz, 1
H, cis/trans), 2.57 (dd, J = 7.8, 15.7 Hz, 1 H, cis/trans), 3.77 (s, 3
H, cis/trans), 4.06 (d, J = 14.9 Hz, 1 H, cis/trans), 4.30 (ddd, J =
4.7, 7.8, 8.6 Hz, 1 H, cis/trans), 4.64 (d, J = 14.9 Hz, 1 H, cis), 4.65
(d, J = 14.9 Hz, 1 H, trans), 5.95 (dd, J = 2.2, 6.3 Hz, 1 H, trans),
6.05 (d, J = 4.7 Hz, 1 H, cis), 6.82 (d, J = 8.6 Hz, 2 H, cis/trans),
7.15 (d, J = 8.6 Hz, 2 H, cis/trans).
1-Propenyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl Acetate (2n)
Colorless oil.
IR (CHCl3): 1707, 1674 cm–1.
13C NMR: d = –4.8, –4.7, 18.2, 21.2, 25.8, 37.8, 44.2, 55.6, 66.6,
83.4, 114.4, 128.5, 130.2, 159.5, 170.7, 173.0.
1H NMR: d = 1.68 (dd, J = 1.5, 6.2 Hz, 3 H), 2.08 (s, 3 H), 2.23–
2.80 (m, 4 H), 5.12 (qd, J = 7.0, 14.0 Hz, 1 H), 6.45 (d, J = 5.5 Hz,
1 H), 6.62 (dd, J = 1.5, 14.0 Hz, 1 H).
13C NMR: d = 15.7, 21.3, 26.6, 28.9, 83.12, 109.45, 122.2, 170.7,
173.4.
(2S,3R,4R)-1-Benzyl-5-oxopyrrolidine-2,3,4-triyl Triacetate
(2f)
Colorless oil; [a]D25 +22.9 (c 0.11, EtOH).
IR (CHCl3): 2252, 1753, 1731, 1371 cm–1.
1H NMR: d = 1.90 (s, 3 H), 2.09 (s, 3 H), 2.20 (s, 3 H), 4.36 (d, J =
14.9 Hz, 1 H), 4.67 (d, J = 14.9 Hz, 1 H), 5.22 (dd, J = 1.6, 3.9 Hz,
1 H), 5.37 (d, J = 3.9 Hz, 1 H), 6.06 (d, J = 1.5 Hz, 1 H), 7.20–7.40
(m, 5 H).
13C NMR: d = 20.6, 20.7, 45.0, 73.3, 76.0, 83.6, 128.1, 128.3, 128.9,
135.3, 167.9, 169.7, 169.8, 169.9.
(5R)-2-Acetoxy-1,5-pyrrolidinedicarboxylic Acid 5-Methyl 1-
tert-Butyl Diester (4a)
Colorless oil.
IR (CHCl3): 2253, 1734, 1707, 1380 cm–1.
1H NMR: d = 1.43 (s, 9 H), 1.95–2.15 (m, 3 H), 2.08 (s, 3 H), 2.30–
2.40 (m, 1 H), 3.77 (s, 3 H), 4.20–4.35 (m, 1 H), 6.48 (br s, 1 H).
13C NMR: d = 22.3, 27.2, 27.9, 28.3, 32.2, 32.7, 52.3, 59.6, 60.2,
81.5, 83.4, 84.0, 152.7, 153.0, 166.6, 170.5, 170.7, 172.6, 172.9.
(2S,3R,4R)-1-Allyl-5-oxopyrrolidine-2,3,4-triyl Triacetate (2g)
White solid; mp 48–49 °C; trans (2S,3R)/cis (2R,3R), 86:14.
IR (CHCl3): 1732, 1675, 1646 cm–1.
1H NMR: d = 2.09 (s, 3 H), 2.11 (s, 3 H), 2.15 (s, 3 H), 3.45 (dd,
J = 7.0, 15.7 Hz, 1 H), 4.11 (dd, J = 5.5, 15.7 Hz, 1 H, cis, 14%),
5.14–5.36 (m, 4 H), 5.62–5.82 (m, 1 H), 6.11 (d, J = 1.5 Hz, 1 H),
6.31 (d, J = 4.7 Hz, 1 H, cis).
(5R)-2-Acetoxy-1,5-pyrrolidinedicarboxylic Acid 1,5-di-tert-
Butyl Diester (4b)
White solid; mp 74–76 °C.
Synthesis 2006, No. 5, 875–879 © Thieme Stuttgart · New York